Roquefort Therapeutics
- 6th December 2022
Through a brutal year for biostocks a company that has continued to build a platform for the development of its suite of novel anti-cancer medicines
Client: Total Market Solutions
Client: Total Market Solutions
Client: Total Market Solutions
Client: Total Market Solutions
Client: Total Market Solutions
Client: Total Market Solutions
Client: Total Market Solutions
Client: Total Market Solutions
Client: Total Market Solutions
Client: Total Market Solutions
With acknowledgement to Unsplash for many of the images used in this section